Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Pasternak

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 18, 2025
Establishing a CYP3A5 genotype-guided tacrolimus dosing protocol in adult kidney transplant recipientsAmy L Pasternak, Christopher Zimmerman, Jeong M Park
Pharmacogenomics|September 8, 2020
The future of research into genetics and the precision dosing of tacrolimus: what do we need to know?Jing Zhu, Amy L Pasternak, Daniel J Crona
Pharmacogenomics|April 10, 2018
CYP3A pharmacogenetic association with tacrolimus pharmacokinetics differs based on route of drug administrationAmy L Pasternak, Lu Zhang, Daniel L Hertz
Acta Biologica Et Medica Germanica|January 1, 1978
[Detection of tumor-associated cell membrane antigens of UV-induced mouse sarcoma by the ferritin-hybrid antibody method]A Lageman, L Pasternak, G Pasternak, et al.
Pharmacotherapy|June 15, 2021
Impact of CYP3A5 phenotype on tacrolimus time in therapeutic range and clinical outcomes in pediatric renal and heart transplant recipientsAbbie D Leino, Jeong M Park, Amy L Pasternak
Therapeutic Drug Monitoring|January 10, 2023
Predictive Capacity of Population Pharmacokinetic Models for the Tacrolimus Dose Requirements of Pediatric Solid Organ Transplant RecipientsAmy L Pasternak, Jeong M Park, Manjunath P Pai
The Pharmacogenomics Journal|October 17, 2019
Challenges to assess substrate-dependent allelic effects in CYP450 enzymes and the potential clinical implicationsLauren A Marcath, Amy L Pasternak, Daniel L Hertz
European Journal of Cancer|May 1, 1976
Cross-reactions among mouse tumors of different etiology as detected by macrophage electrophoretic mobility (MEM) testL Pasternak, H L Jenssen, H Köhler, et al.
NPJ Genomic Medicine|November 4, 2020
Prevalence and types of inconsistencies in clinical pharmacogenetic recommendations among major U.S. sourcesTyler Shugg, Amy L Pasternak, Bianca London, et al.
Folia Phoniatrica|January 1, 1971
[Comparison of microphone, diaphanographic and glottographic signals, using the laryngograph]B Vallancien, B Gautheron, L Pasternak, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 18, 2025
Establishing a CYP3A5 genotype-guided tacrolimus dosing protocol in adult kidney transplant recipientsAmy L Pasternak, Christopher Zimmerman, Jeong M Park
Pharmacogenomics|September 8, 2020
The future of research into genetics and the precision dosing of tacrolimus: what do we need to know?Jing Zhu, Amy L Pasternak, Daniel J Crona
Pharmacogenomics|April 10, 2018
CYP3A pharmacogenetic association with tacrolimus pharmacokinetics differs based on route of drug administrationAmy L Pasternak, Lu Zhang, Daniel L Hertz
Acta Biologica Et Medica Germanica|January 1, 1978
[Detection of tumor-associated cell membrane antigens of UV-induced mouse sarcoma by the ferritin-hybrid antibody method]A Lageman, L Pasternak, G Pasternak, et al.
Pharmacotherapy|June 15, 2021
Impact of CYP3A5 phenotype on tacrolimus time in therapeutic range and clinical outcomes in pediatric renal and heart transplant recipientsAbbie D Leino, Jeong M Park, Amy L Pasternak
Therapeutic Drug Monitoring|January 10, 2023
Predictive Capacity of Population Pharmacokinetic Models for the Tacrolimus Dose Requirements of Pediatric Solid Organ Transplant RecipientsAmy L Pasternak, Jeong M Park, Manjunath P Pai
The Pharmacogenomics Journal|October 17, 2019
Challenges to assess substrate-dependent allelic effects in CYP450 enzymes and the potential clinical implicationsLauren A Marcath, Amy L Pasternak, Daniel L Hertz
European Journal of Cancer|May 1, 1976
Cross-reactions among mouse tumors of different etiology as detected by macrophage electrophoretic mobility (MEM) testL Pasternak, H L Jenssen, H Köhler, et al.
NPJ Genomic Medicine|November 4, 2020
Prevalence and types of inconsistencies in clinical pharmacogenetic recommendations among major U.S. sourcesTyler Shugg, Amy L Pasternak, Bianca London, et al.
Folia Phoniatrica|January 1, 1971
[Comparison of microphone, diaphanographic and glottographic signals, using the laryngograph]B Vallancien, B Gautheron, L Pasternak, et al.
Pageof 6